Clinical Trial Details
— Status: Completed
Administrative data
| NCT number |
NCT06237244 |
| Other study ID # |
IR.SUMS.MED.REC.1402.252 |
| Secondary ID |
|
| Status |
Completed |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
December 1, 2018 |
| Est. completion date |
September 1, 2023 |
Study information
| Verified date |
February 2024 |
| Source |
Shiraz University of Medical Sciences |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational [Patient Registry]
|
Clinical Trial Summary
In this retrospective study from professor Kojuri clinic registry, total number of 1017
patients with first angiography were included and all data were recorded from registry.
Insulin resistance was calculated using laboratory data
Description:
This was an analytical cross-sectional retrospective study involving patients with suspected
CAD who underwent coronary angiography between December 2018 and May 2023. The information
was obtained from patients referred to the outpatient cardiovascular clinic (Professor Kojuri
Cardiology Clinic, Shiraz, Iran, www.kojuriclinic.com). Data was extracted from Professor
Kojuri Cardiology Clinic database, including patient's information about the clinical
history, presence or absence of specific diseases, angiography/angioplasty results,
medications, and laboratory values.
A total of 14,708 patients who had undergone coronary angiography at least once were
examined. After applying exclusion criteria, 1017 eligible cases were selected for data
analysis.
The following data was recorded for the included patients: demographic data, past medical
history (such as DM, hypertension, etc.), systolic and diastolic blood pressure, weight and
height, fasting plasma glucose (FPG), hemoglobin A1c (HbA1c), total cholesterol (TC),
triglyceride (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein
cholesterol (HDL-C), and serum creatinine (Cr). Body mass index (BMI) was calculated as
weight (Kg) divided by the square of height (m2). Obesity was defined as BMI ≥ 30 Kg/m2.
Laboratory values were selected from the time before angiography, and if not available, from
the time shortly after the angiography. This helped us find those values which could best
represent the metabolic state of patients at the time of angiography, while reducing the
confounding effect of statin use.
